YALE UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
- Conditions
- Decompensated Heart Failure
- Interventions
- Other: Placebo
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Yale University
- Target Recruit Count
- 20
- Registration Number
- NCT03440970
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
- Conditions
- ContraceptionContraceptive Device; ComplicationsSterility, Female
- Interventions
- Device: Intrauterine Device (IUD)Device: EssureProcedure: Laparoscopic sterilization
- First Posted Date
- 2018-02-20
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 89203
- Registration Number
- NCT03438682
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
Post-Market Surveillance With a Novel mHealth Platform
- Conditions
- Atrial FibrillationGastrectomy
- Interventions
- Device: A mobile health platform
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2021-03-19
- Lead Sponsor
- Yale University
- Target Recruit Count
- 60
- Registration Number
- NCT03436082
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Yale New Haven Hospital, New Haven, Connecticut, United States
Associations of Socioeconomic Adversity and Sleep With Allostatic Load Among Toddlers
- Conditions
- Sleep Disorder
- Interventions
- Other: Monitoring SleepOther: stress biomarkers
- First Posted Date
- 2018-02-05
- Last Posted Date
- 2021-12-07
- Lead Sponsor
- Yale University
- Target Recruit Count
- 100
- Registration Number
- NCT03419871
- Locations
- 🇺🇸
Yale New Haven Hospital Primary Care Center, New Haven, Connecticut, United States
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
- Conditions
- Kidney Transplant; Complications
- Interventions
- Drug: Tacrolimus, Extended Release, (Envarsus Xr)
- First Posted Date
- 2018-01-25
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Yale University
- Target Recruit Count
- 28
- Registration Number
- NCT03410654
- Locations
- 🇺🇸
Yale New Haven Transplantation Center, New Haven, Connecticut, United States
Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients
- Conditions
- Alcoholic Liver Disease
- Interventions
- Behavioral: Text Message
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Yale University
- Target Recruit Count
- 15
- Registration Number
- NCT03402256
- Locations
- 🇺🇸
Yale Transplantation Center/Yale-New Haven Hospital, New Haven, Connecticut, United States
Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2021-11-05
- Lead Sponsor
- Yale University
- Target Recruit Count
- 32
- Registration Number
- NCT03400501
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use
- Conditions
- Alcohol DrinkingMarijuana
- Interventions
- Behavioral: Text Messaging and Brief Negotiation Interview
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- Yale University
- Target Recruit Count
- 10
- Registration Number
- NCT03401333
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
Ketamine in Borderline Personality Disorder
- Conditions
- Borderline Personality Disorder
- Interventions
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Yale University
- Target Recruit Count
- 22
- Registration Number
- NCT03395314
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸Yale New Haven Hospital, New Haven, Connecticut, United States
Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)
- Conditions
- Cannabis Use Disorder
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Yale University
- Target Recruit Count
- 228
- Registration Number
- NCT03386487
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
🇺🇸Columbia University Medical College / New York State Psychiatric Institute, New York, New York, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States